In the April issue of PME we see how, despite steady improvements across Europe in a range of healthcare indicators, timely access to health services remains an exception.
Amgen’s Sue Rees argues the case for pharmacovigilance as a strategic asset that can protect products by looking out for those that use them.
And we speak to Merck Consumer Health’s Uta Kemmerich-Keil about how she wants to add value to her business and society at large.
The issue also looks at SEO in healthcare, the role of patient art in generating insights and virtual meetings.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
